Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06095557 · ClinicalTrials.gov registry record · NA

MCG Discovery Study in Emergency Departments

A NA study of NSTEMI - Non-ST Segment Elevation MI and ACS (Acute Coronary Syndrome), sponsored by SB Technology.

Completed
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT06095557 is a NA study of NSTEMI - Non-ST Segment Elevation MI and ACS (Acute Coronary Syndrome) that has completed, run by SB Technology. The registered enrollment target is 124 participants, below the 16,397-participant average among 4 other NSTEMI - Non-ST Segment Elevation MI trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06095557, a NA study of NSTEMI - Non-ST Segment Elevation MI and ACS (Acute Coronary Syndrome), has completed, sponsored by SB Technology.

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.

Interventions

  • DEVICE Sponsor MCG device

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2023-10-30
Est. Completion 2025-07-08
Phase NA

Sponsor

SB Technology

3 total trials

What the Registry Record Tells You About NCT06095557

The ClinicalTrials.gov registry entry for NCT06095557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 16,397-participant average among 4 other NSTEMI - Non-ST Segment Elevation MI trials with a reported enrollment target (99% lower). The listed sponsor is SB Technology, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with NSTEMI - Non-ST Segment Elevation MI appearing as the primary indexed condition, and to 1 intervention - of which Sponsor MCG device is the first listed.

NCT06095557 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06095557 about?

NCT06095557 is a clinical study titled "MCG Discovery Study in Emergency Departments". This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.

What is the current status of trial NCT06095557?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2023-10-30. Estimated completion is 2025-07-08.

What conditions does trial NCT06095557 study?

This clinical trial studies the following conditions: NSTEMI - Non-ST Segment Elevation MI, ACS (Acute Coronary Syndrome).

What interventions are being tested in trial NCT06095557?

The interventions under investigation include: Sponsor MCG device (DEVICE).

Who is sponsoring clinical trial NCT06095557?

This trial is sponsored by SB Technology, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06095557 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for NSTEMI - Non-ST Segment Elevation MI

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.